Single-Use Bioprocessing Systems Market Is Gaining Significant Traction with Alfa Laval Introducing Cultureone, a Separator System for Single-Use Culture Processing

Single-use pharmaceuticals production is an efficient production model for small and medium-sized pharmaceutical manufacturing facilities. The use of these systems allows the production of a very high volume of active ingredients with a simplified process. With single-use production, the number of visits to the pharmaceutical production laboratory is considerably reduced. As far as geographical impact is considered, North America seems to be gaining significant traction in the single-use bioprocessing systems market. This robust traction is attributed to the large presence of major biopharmaceutical companies across the U.S. On the contrary, Asia Pacific is exhibiting a positive outlook due to rising investment in the biopharmaceutical industry in China.

The global single-use bioprocessing market by revenue is expected to grow at a CAGR of 17% during the period 2021-2026.

LIMITED TIME OFFER – Hurry Up!

Exclusive offer!!! Purchase the report at a discounted rate!!!

Get Discount for Buyers USD 2000 OFF On Any Research Report

Buy Now and Get Instant Discount: https://www.coherentmarketinsights.com/promo/buynow/1754

Single-Use Bioprocess Systems Market by Category
Component
Bioreactors
Cell Culture Bioreactors
Fermentation Bioreactors
Mixers
Bioprocess Containers
Transfer and Storage Bags
Sampling Systems
Filtration Systems
Chromatography Columns
Probes & Sensors
Tubing Assemblies
Connectors & Clamps
Filling Systems

Application
Research & Development (R&D)
GMP and Commercial Production

End-User
Biopharmaceutical Companies
Contract Research Organizations
Contract Manufacturing Organizations
Research Institutes

Since single-use bioprocessing systems have great potential to significantly reduce the overall operating cost of a manufacturing process, they have great potential to enhance the competitiveness of the market. The demand for biopharmaceuticals has significantly in the recent past, typically in the manufacturing of vaccines, gene therapies, blood and blood components, etc. Key companies in the field of drug development are focused on R&D activities, in order to innovate novel medicines and therapies. Recently, in April 2021, CystecPharma, a pharmaceutical company, inaugurated a new subsidiary Nantong Crystec Pharmaceutical R&D Co. Ltd. in China. Thus, these factors can augment growth of the single-use bioprocessing systems market.

Single-use pharmaceuticals production can be attributed to three main factors: the plug and play characteristic, minimal energy consumption, and high volume production with minimized wastage. Single-use systems are ideal for biotechnology products, which are made up of inactive ingredients. These inactive ingredients are commonly used as growth media or as vehicle liquids. That being said, there are certain factors that could potentially limit market growth. For instance, there are challenges related to leachables and extractables, which could lead to a negative impact on the market growth. Besides, issues regarding waste disposal and scalability could impede growth of the single-use bioprocessing systems market.

The plug-and-play characteristic of single-use bioprocessing systems allows for minimal contamination. A thorough inspection of the manufacturing area is essential for any manufacturing process to prevent cross-contamination. An effective system for cross-contamination elimination is necessary. Another key factor governing the market development is lower costs and lower environmental impact offered by single-use bioprocessing systems. This, in turn, has led to increase in the application of disposables in the bioprocessing industry. Hence, such factors could potentially stimulate growth of the single-use bioprocessing systems market. Recently, in June 2021, Alfa Laval launched CultureOne, a separator system for single-use culture processing.

Read more @ https://www.coherentmarketinsights.com/market-insight/single-use-bioprocessing-systems-market-1754

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle,
WA 98154, U.S.
Phone:
US: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com

About Us:
Coherent Market Insights (CMI) is a global market intelligence and consulting organization focused on assisting plethora of clients achieve transformational growth by helping them make critical business decisions. The company is headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. The company’s client base includes players from across various business verticals in over 47 countries globally. It takes pride in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and start-ups looking to establish a foothold in the market.

This release was published on openPR.